Azenta, Inc. Stock price

Equities

AZTA

US1143401024

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
58.18 USD -2.23% Intraday chart for Azenta, Inc. -10.68% -10.68%
Sales 2024 * 704M Sales 2025 * 743M Capitalization 3.24B
Net income 2024 * -27M Net income 2025 * -17M EV / Sales 2024 * 4.61 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 4.37 x
P/E ratio 2024 *
-112 x
P/E ratio 2025 *
-165 x
Employees 3,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 78.97%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Azenta, Inc.

1 day-2.23%
1 week-10.68%
Current month-10.70%
1 month-9.32%
3 months-5.90%
6 months+14.51%
Current year-10.68%
More quotes
1 week
58.09
Extreme 58.09
65.09
1 month
58.09
Extreme 58.09
67.77
Current year
58.09
Extreme 58.09
69.16
1 year
36.01
Extreme 36.01
69.16
3 years
36.01
Extreme 36.01
124.79
5 years
21.19
Extreme 21.19
124.79
10 years
8.33
Extreme 8.33
124.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 10-04-04
Director of Finance/CFO 50 23-10-15
Chief Tech/Sci/R&D Officer - 17-06-30
Members of the board TitleAgeSince
Director/Board Member 63 Jan. 29
Director/Board Member 65 Jan. 29
Chief Executive Officer 65 10-04-04
More insiders
Date Price Change Volume
24-03-18 58.18 -2.23% 758,228
24-03-15 59.51 +0.42% 1,951,059
24-03-14 59.26 -7.57% 790,328
24-03-13 64.11 -0.90% 407,708
24-03-12 64.69 -0.69% 363,419

Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT

More quotes
Azenta, Inc. is a provider of life science sample exploration and management solutions for the life sciences market. The Company operates through two segments. The Life Sciences Products segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments. The segment’s product offerings include automated cold storage systems, cryogenic storage systems, consumables and instruments and the associated services business for these products. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, as well as sample-based laboratory services to advance scientific research and support drug development. The segment’s service offerings include sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
58.18 USD
Average target price
72 USD
Spread / Average Target
+23.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Azenta, Inc. - Nasdaq